Susquehanna Portfolio Strategies’s Organogenesis Holdings ORGO Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,294	Closed	-$131K	–	1063
2025 Q4	$131K	Sell	25,294 -14,024	-36%	-$67.9K	﹤0.01%	971
2025 Q3	$166K	Buy	39,318 +14,024	+55%	+$65.2K	﹤0.01%	994
2025 Q2	$92.6K	Buy	+25,294	New	+$94.3K	﹤0.01%	820
2024 Q4	–	Sell	-56,083	Closed	-$160K	–	240
2024 Q3	$160K	Sell	56,083 -13,155	-19%	-$36.9K	0.01%	323
2024 Q2	$194K	Sell	69,238 -8,036	-10%	-$21.6K	0.01%	467
2024 Q1	$219K	Sell	77,274 -15,829	-17%	-$53.8K	0.01%	721
2023 Q4	$381K	Buy	+93,103	New	+$261K	0.01%	811

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Susquehanna Portfolio Strategies's ORGO Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 25,294 shares — an estimated $131K sold.

Susquehanna Portfolio Strategies first reported a position in ORGO in Q4 2023 and held it in 7 quarters. The position peaked at $381K in Q4 2023. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Susquehanna Portfolio Strategies reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 25,294 Organogenesis Holdings shares in Q1 2026, an estimated $131K.
Susquehanna Portfolio Strategies first reported a position in Organogenesis Holdings in Q4 2023 and held it in 7 quarters.
Susquehanna Portfolio Strategies's Organogenesis Holdings position peaked at $381K in Q4 2023.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.